EGFR and pancreatic neoplasm: Selective uptake by EGFR‐expressing pancreatic cancer cells via active targetingReduced hypoxia‐induced gemcitabine resistance in miR‐519c under‐expressed pancreatic cancerSuperior tumor eradication with chemotherapy, with minimal toxicity